News

Global Perspective Newsletter for February 2020

27 February 2020 – The February 2020 edition of our Global Perspective Newsletter is now available. Read the latest news from ADI, our partners and member associations, including updates on the upcoming World Alzheimer's Month, World Alzheimer Report, and much more. [read more]

Roche to end DIAN-TU-001 study for rare Autosomnal dominant Alzheimer's disease

10 February 2020 – Roche announces discontinuation of part of phase 2/3 study for people with early onset Autosomal dominant Alzheimer's disease. [read more]

Global Perspective Newsletter for December 2019

10 December 2019 – The December 2019 edition of our Global Perspective Newsletter is now available. Read the latest news from ADI, our partners and member associations, including updates on the upcoming World Alzheimer's Month, World Alzheimer Report, and much more. [read more]

ADI and DAI invite you to a joint webinar on dementia and rights

11 December 2019 – ADI is happy to announce that we will be hosting a joint webinar, Dementia & rights; from principles to practice, with Dementia Alliance International (DAI) on 27 February 2020. [read more]

China approves first drug for mild to moderate Alzheimer's in 17 years

4 November 2019 – Chinese Pharmaceutical Company Green Valley announced over the weekend that their drug Oligomannate (GV-971) has been granted conditional approval by the National Medical Products Administration (NMPA) as a new drug for the treatment of “mild to moderate Alzheimer's disease and improving cognitive function”. [read more]

Biogen and Eisai announce plans to file for market approval of Alzheimer's drug

22 October 2019 – Biogen and Eisai today announced that they will file for market approval for the drug aducanumab, an investigational treatment for early Alzheimer’s disease, following new analysis showing reduced clinical decline in people with early Alzheimer’s disease. [read more]

Dementia given high priority at G20 Health Ministers Meeting

21 October 2019 – Following advocacy by ADI and its members, dementia was given high priority in the Okayama Declaration of the G20 Health Ministers, displaying an ongoing commitment of the G20 to addressing the biggest health and social care crisis of the 21st century. [read more]

ADI interviewed by major Japanese newspaper ahead of G20 meeting

20 October 2019 – During a trip to Japan in October, Paola Barbarino was interviewed by Asahi Shimbun newspaper in Tokyo. [read more]

Spanish government launches national plan to tackle dementia

15 October 2019 – It was today announced by the Spanish Ministry of Health, Consumption and Social Welfare that they had adopted a national dementia plan. The National Alzheimer's Plan 2019-2023 will be a crucial support for the Spanish population affected by dementia now and in the future. [read more]

World Alzheimer Report 2019: Attitudes to dementia

20 September 2019 – The World Alzheimer Report 2019 analyses findings of the world’s largest survey on attitudes to dementia, as well as expert essays and case studies from across the world. [Read more]